A novel role of IKKα in the mediation of UVB-induced G0/G1 cell cycle arrest response by suppressing Cyclin D1 expression

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1803, Issue 2, 2010, Pages 323-332

  Song, Lun ^a   Dong, Wen ^a   Gao, Ming ^a   Li, Jingxia ^b   Hu, Meiru ^a   Guo, Ning ^a   Huang, Chuanshu ^b  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell cycle arrest; Cyclin D1; IKK ; UVB

Indexed keywords

CYCLIN D1; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; I KAPPA B KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEASOME;

ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL DAMAGE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SKIN CARCINOGENESIS; TRANSCRIPTION REGULATION; ULTRAVIOLET B RADIATION; ANIMAL; CELL CYCLE; DRUG ANTAGONISM; GENETICS; HUMAN; METABOLISM; MOUSE; MOUSE MUTANT; PHYSIOLOGY; RADIATION EXPOSURE; SIGNAL TRANSDUCTION; SKIN; SUNLIGHT; ULTRAVIOLET RADIATION;

ANIMALS; CELL CYCLE; CYCLIN D1; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; I-KAPPA B KINASE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, KNOCKOUT; NF-KAPPA B; PROTEASOME ENDOPEPTIDASE COMPLEX; SKIN; SUNLIGHT; ULTRAVIOLET RAYS;

EID: 77649272879     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2010.01.006     Document Type: Article

References (38)

1. Lee E., Koo J., and Berger T. UVB phototherapy and skin cancer risk: a review of the literature. Int. J. Dermatol. 44 (2005) 355-360
2. Johansson M., and Persson J.L. Cancer therapy: targeting cell cycle regulators. Anticancer Agents Med. Chem. 8 (2008) 723-731
3. Kim J.K., and Diehl J.A. Nuclear cyclin D1: an oncogenic driver in human cancer. J. Cell. Physiol. 220 (2009) 292-296
4. Alao J.P. The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention. Mol. Cancer 6 (2007) 24
5. Sherr C.J., and Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13 (1999) 1501-1512
6. Albanese C., Johnson J., Watanabe G., Eklund N., Vu D., Arnold A., and Pestell R.G. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270 (1995) 23589-23597
7. Albanese C., Wu K., D'Amico M., Jarrett C., Joyce D., Hughes J., Hulit J., Sakamaki T., Fu M., Ben-Ze'ev A., Bromberg J.F., Lamberti C., Verma U., Gaynor R.B., Byers S.W., and Pestell R.G. IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf. Mol. Biol. Cell 14 (2003) 585-599
8. Cao Y., Bonizzi G., Seagroves T.N., Greten F.R., Johnson R., Schmidt E.V., and Karin M. IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development. Cell 107 (2001) 763-775
9. J.R. Brown, E. Nigh, R.J. Lee, H. Ye, M.A. Thompson, F. Saudou, R.G. Pestell, M.E. Greenberg, Fos family members induce cell cycle entry by activating cyclin D1, Mol. Cell Biol. 18 (1998) 5609-5619.
10. Lopez-Bergami P., Huang C., Goydos J.S., Yip D., Bar-Eli M., Herlyn M., Smalley K.S., Mahale A., Eroshkin A., Aaronson S., and Ronai Z. Rewired ERK-JNK signaling pathways in melanoma. Cancer Cells 11 (2007) 447-460
11. Lavoie J.N., L'Allemain G., Brunet A., Muller R., and Pouyssegur J. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 271 (1996) 20608-20616
12. Diehl J.A., Zindy F., and Sherr C.J. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev. 11 (1997) 957-972
13. Diehl J.A., Cheng M., Roussel M.F., and Sherr C.J. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12 (1998) 3499-3511
14. Casanovas O., Miro F., Estanyol J.M., Itarte E., Agell N., and Bachs O. Osmotic stress regulates the stability of cyclin D1 in a p38SAPK2-dependent manner. J. Biol. Chem. 275 (2000) 35091-35097
15. Thoms H.C., Dunlop M.G., and Stark L.A. p38-mediated inactivation of cyclin D1/cyclin-dependent kinase 4 stimulates nucleolar translocation of RelA and apoptosis in colorectal cancer cells. Cancer Res. 67 (2007) 1660-1669
16. Okabe H., Lee S.H., Phuchareon J., Albertson D.G., McCormick F., and Tetsu O. A critical role for FBXW8 and MAPK in cyclin D1 degradation and cancer cell proliferation. PLoS ONE 1 (2006) e128
17. Hayden M.S., and Ghosh S. Shared principles in NF-kappaB signaling. Cell 132 (2008) 344-362
18. Anest V., Hanson J.L., Cogswell P.C., Steinbrecher K.A., Strahl B.D., and Baldwin A.S. A nucleosomal function for IkappaB kinase-alpha in NF-kappaB-dependent gene expression. Nature 423 (2003) 659-663
19. Yamamoto Y., Verma U.N., Prajapati S., Kwak Y.T., and Gaynor R.B. Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression. Nature 423 (2003) 655-659
20. Kaisho T., Takeda K., Tsujimura T., Kawai T., Nomura F., Terada N., and Akira S. IkappaB kinase alpha is essential for mature B cell development and function. J. Exp. Med. 193 (2001) 417-426
21. Mills D.M., Bonizzi G., Karin M., and Rickert R.C. Regulation of late B cell differentiation by intrinsic IKKalpha-dependent signals. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 6359-6364
22. Hu Y., Baud V., Delhase M., Zhang P., Deerinck T., Ellisman M., Johnson R., and Karin M. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. Science 284 (1999) 316-320
23. Li Q., Lu Q., Hwang J.Y., Buscher D., Lee K.F., Izpisua-Belmonte J.C., and Verma I.M. IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes Dev. 13 (1999) 1322-1328
24. Sil A.K., Maeda S., Sano Y., Roop D.R., and Karin M. IkappaB kinase-alpha acts in the epidermis to control skeletal and craniofacial morphogenesis. Nature 428 (2004) 660-664
25. Descargues P., Sil A.K., and Karin M. IKKalpha, a critical regulator of epidermal differentiation and a suppressor of skin cancer. EMBO J. 27 (2008) 2639-2647
26. Park E., Zhu F., Liu B., Xia X., Shen J., Bustos T., Fischer S.M., and Hu Y. Reduction in IkappaB kinase alpha expression promotes the development of skin papillomas and carcinomas. Cancer Res. 67 (2007) 9158-9168
27. Zhu F., Park E., Liu B., Xia X., Fischer S.M., and Hu Y. Critical role of IkappaB kinase alpha in embryonic skin development and skin carcinogenesis. Histol. Histopathol. 24 (2009) 265-271
28. Song L., Li J., Zhang D., Liu Z.G., Ye J., Zhan Q., Shen H.M., Whiteman M., and Huang C. IKKbeta programs to turn on the GADD45alpha-MKK4-JNK apoptotic cascade specifically via p50 NF-kappaB in arsenite response. J. Cell Biol. 175 (2006) 607-617
29. Song L., Li J., Hu M., and Huang C. Both IKKalpha and IKKbeta are implicated in the arsenite-induced AP-1 transactivation correlating with cell apoptosis through NF-kappaB activity-independent manner. Exp. Cell Res. 314 (2008) 2187-2198
30. Ouyang W., Ma Q., Li J., Zhang D., Liu Z.G., Rustgi A.K., and Huang C. Cyclin D1 induction through IkappaB kinase beta/nuclear factor-kappaB pathway is responsible for arsenite-induced increased cell cycle G1-S phase transition in human keratinocytes. Cancer Res. 65 (2005) 9287-9293
31. Wang X., Ju W., Renouard J., Aden J., Belinsky S.A., and Lin Y. 17-allylamino-17-demethoxygeldanamycin synergistically potentiates tumor necrosis factor-induced lung cancer cell death by blocking the nuclear factor-kappaB pathway. Cancer Res. 66 (2006) 1089-1095
32. Hu Y., Baud V., Oga T., Kim K.I., Yoshida K., and Karin M. IKKalpha controls formation of the epidermis independently of NF-kappaB. Nature 410 (2001) 710-714
33. Song L., Li J., Ye J., Yu G., Ding J., Zhang D., Ouyang W., Dong Z., Kim S.O., and Huang C. p85alpha acts as a novel signal transducer for mediation of cellular apoptotic response to UV radiation. Mol. Cell. Biol. 27 (2007) 2713-2731
34. Ouyang W., Zhang D., Li J., Verma U.N., Costa M., and Huang C. Soluble and insoluble nickel compounds exert a differential inhibitory effect on cell growth through IKKalpha-dependent cyclin D1 down-regulation. J. Cell. Physiol. 218 (2009) 205-214
35. Kwak Y.T., Li R., Becerra C.R., Tripathy D., Frenkel E.P., and Verma U.N. IkappaB kinase alpha regulates subcellular distribution and turnover of cyclin D1 by phosphorylation. J. Biol. Chem. 280 (2005) 33945-33952
36. Moreno-Maldonado R., Ramirez A., Navarro M., Fernandez-Acenero M.J., Villanueva C., Page A., Jorcano J.L., Bravo A., and Llanos Casanova M. IKKalpha enhances human keratinocyte differentiation and determines the histological variant of epidermal squamous cell carcinomas. Cell Cycle 7 (2008) 2021-2029
37. Tu Z., Prajapati S., Park K.J., Kelly N.J., Yamamoto Y., and Gaynor R.B. IKK alpha regulates estrogen-induced cell cycle progression by modulating E2F1 expression. J. Biol. Chem. 281 (2006) 6699-6706
38. Park K.J., Krishnan V., O'Malley B.W., Yamamoto Y., and Gaynor R.B. Formation of an IKKalpha-dependent transcription complex is required for estrogen receptor-mediated gene activation. Mol. Cell 18 (2005) 71-82